Inogen, Inc.
NASDAQ:INGNMedical - Devices
+$0.05 today
- Market cap
- $140.93M
- Beta
- 1.60
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$0.91
Volume 0.22M
Average 0.33M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Inogen, Inc.
NASDAQ:INGN
Intrinsic Alpha fair value
Locked
Current Price
$5.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -2.6% | +6.4% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at -2.6% over three years. Forward estimates point to Revenue at +6.4% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Sight Sciences, Inc. NASDAQ:SGHT | $601.92M | $10.83 | Not rated | -7.5 | +59.94% |
Eupraxia Pharmaceuticals Inc. NASDAQ:EPRX | $548.02M | $8.15 | Not rated | -8.5 | -1.45% |
Shoulder Innovations, Inc. NYSE:SI | $432.88M | $20.69 | Not rated | -8.4 | +46.75% |
Quanterix Corporation NASDAQ:QTRX | $139.11M | $2.93 | Not rated | -1.5 | -65.65% |
Health Catalyst, Inc. NASDAQ:HCAT | $114.99M | $1.51 | Undervalued | -0.5 | -36.45% |
Perspective Therapeutics, Inc. AMEX:CATX | $113.89M | $0.94 | Not rated | -0.0 | -63.02% |
Solana Company NASDAQ:HSDT | $101.01M | $1.73 | Not rated | -0.9 | -48.92% |
Outset Medical, Inc. NASDAQ:OM | $70.32M | $3.73 | Not rated | -1.2 | -34.46% |
Nano-X Imaging Ltd. NASDAQ:NNOX | $25.36M | $0.32 | Not rated | -1.5 | -78.79% |
SANUWAVE Health, Inc. NASDAQ:SNWV | $15.66M | $1.82 | Undervalued | 5.0 | -81.50% |
Continue the stock analysis
Jump to another research area for this company.